Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Smith

Showing results (501-510 of 594) with videos related to

Pageof 60
Sort By:
Regulatory Toxicology and Pharmacology : RTP|August 30, 2016
Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology studyLuc Chouinard, Melanie Felx, Nacera Mellal, et al.
Neurobiology of Disease|April 19, 2023
RGS14 limits seizure-induced mitochondrial oxidative stress and pathology in hippocampusN H Harbin, D J Lustberg, C Hurst, et al.
Contact (Thousand Oaks (Ventura County, Calif.))|February 8, 2024
Contact-FP: A Dimerization-Dependent Fluorescent Protein Toolkit for Visualizing Membrane Contact Site DynamicsGregory E Miner, Sidney Y Smith, Wendy K Showalter, et al.
AIDS Patient Care and Stds|November 1, 2003
Optimizing care for African-American HIV-positive patientsKimberly Y Smith, Andre Brutus, Ronald Cathcart, et al.
The Lancet. HIV|July 22, 2017
Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b studyCatherine Orrell, Debbie P Hagins, Elena Belonosova, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 11, 2015
Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based studyCynthia L Leibson, Kirsten Hall Long, Jeanine E Ransom, et al.
Head & Neck|March 1, 2021
Survival outcomes in locally advanced cutaneous squamous cell carcinoma presenting with clinical perineural invasion aloneAntonious Z Hazim, Clay T Reed, Katharine A Price, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective StudyAshish V Chintakuntlawar, Kandelaria M Rumilla, Carin Y Smith, et al.
Advanced Drug Delivery Reviews|April 12, 2021
Drug delivery to the pediatric upper airwaySoheila Ali Akbari Ghavimi, Paul M Gehret, Matthew R Aronson, et al.
AIDS (London, England)|September 28, 2002
Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced diseaseHernan Valdez, Elizabeth Connick, Kimberly Y Smith, et al.
Pageof 60

Showing results (501-510 of 594) with videos related to

Sort By:
Pageof 60
Regulatory Toxicology and Pharmacology : RTP|August 30, 2016
Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology studyLuc Chouinard, Melanie Felx, Nacera Mellal, et al.
Neurobiology of Disease|April 19, 2023
RGS14 limits seizure-induced mitochondrial oxidative stress and pathology in hippocampusN H Harbin, D J Lustberg, C Hurst, et al.
Contact (Thousand Oaks (Ventura County, Calif.))|February 8, 2024
Contact-FP: A Dimerization-Dependent Fluorescent Protein Toolkit for Visualizing Membrane Contact Site DynamicsGregory E Miner, Sidney Y Smith, Wendy K Showalter, et al.
AIDS Patient Care and Stds|November 1, 2003
Optimizing care for African-American HIV-positive patientsKimberly Y Smith, Andre Brutus, Ronald Cathcart, et al.
The Lancet. HIV|July 22, 2017
Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b studyCatherine Orrell, Debbie P Hagins, Elena Belonosova, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 11, 2015
Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based studyCynthia L Leibson, Kirsten Hall Long, Jeanine E Ransom, et al.
Head & Neck|March 1, 2021
Survival outcomes in locally advanced cutaneous squamous cell carcinoma presenting with clinical perineural invasion aloneAntonious Z Hazim, Clay T Reed, Katharine A Price, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective StudyAshish V Chintakuntlawar, Kandelaria M Rumilla, Carin Y Smith, et al.
Advanced Drug Delivery Reviews|April 12, 2021
Drug delivery to the pediatric upper airwaySoheila Ali Akbari Ghavimi, Paul M Gehret, Matthew R Aronson, et al.
AIDS (London, England)|September 28, 2002
Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced diseaseHernan Valdez, Elizabeth Connick, Kimberly Y Smith, et al.
Pageof 60